| human | Q5 |
| P106 | occupation | researcher | Q1650915 |
| Q40142694 | A common anti-cytomegalovirus drug, ganciclovir, inhibits HIV-1 replication in human tissues ex vivo |
| Q34132879 | A highly sensitive and dynamic immunofluorescent cytometric bead assay for the detection of HIV-1 p24. |
| Q28534866 | A multi-targeted drug candidate with dual anti-HIV and anti-HSV activity |
| Q35174634 | A new antiviral: chimeric 3TC-AZT phosphonate efficiently inhibits HIV-1 in human tissues ex vivo. |
| Q33609662 | A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2 |
| Q35828692 | Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. |
| Q34408370 | Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues |
| Q37591107 | Acyclovir: a new use for an old drug |
| Q41902559 | An ex vivo Model of HIV-1 Infection in Human Lymphoid Tissue and Cervico-vaginal Tissue |
| Q24305042 | Cell surface expression of CD147/EMMPRIN is regulated by cyclophilin 60 |
| Q35252587 | Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection |
| Q36189825 | Coinfecting viruses as determinants of HIV disease |
| Q33700312 | Contrasting roles for TLR ligands in HIV-1 pathogenesis |
| Q35174673 | Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides |
| Q36888298 | Distinct cytokine/chemokine network in semen and blood characterize different stages of HIV infection |
| Q38651946 | Dual-targeted anti-TB/anti-HIV heterodimers |
| Q42591761 | Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A. |
| Q35941302 | Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirin |
| Q33687702 | Extracellular Vesicles Carry HIV Env and Facilitate Hiv Infection of Human Lymphoid Tissue |
| Q35660103 | Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with Men. |
| Q39466748 | HIV Trafficking Between Blood and Semen During Early Untreated HIV Infection. |
| Q36385010 | HIV-1 imposes rigidity on blood and semen cytokine networks |
| Q36384710 | HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo |
| Q35897398 | HIV-1 vaginal transmission: cell-free or cell-associated virus? |
| Q35897386 | Histocultures (tissue explants) in human retrovirology |
| Q59353573 | Human cytomegalovirus-infected cells release extracellular vesicles that carry viral surface proteins |
| Q34014066 | Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix |
| Q36315592 | Interactions between human immunodeficiency virus type 1 and vaccinia virus in human lymphoid tissue ex vivo |
| Q34585676 | Interleukin-7 facilitates HIV-1 transmission to cervico-vaginal tissue ex vivo |
| Q35625173 | Involvement of GAGs in the activity of pro-inflammatory factors. |
| Q33257138 | Long-term changes of serum chemokine levels in vaccinated military personnel |
| Q37372064 | Mechanisms associated with HIV-1 resistance to acyclovir by the V75I mutation in reverse transcriptase |
| Q37130757 | Microbicides: still a long road to success |
| Q37347339 | Monocytes but Not Lymphocytes Carrying HIV-1 on Their Surface Transmit Infection to Human Tissue Ex Vivo. |
| Q33792231 | Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention |
| Q38342027 | Octasaccharide is the minimal length unit required for efficient binding of cyclophilin B to heparin and cell surface heparan sulphate. |
| Q34045624 | Oxadiazols: a new class of rationally designed anti-human immunodeficiency virus compounds targeting the nuclear localization signal of the viral matrix protein |
| Q35623739 | Semen of HIV-1-infected individuals: local shedding of herpesviruses and reprogrammed cytokine network |
| Q40064352 | Standardization of a cytometric p24-capture bead-assay for the detection of main HIV-1 subtypes |
| Q37357285 | The application of phosphoramidate protide technology to acyclovir confers anti-HIV inhibition. |
| Q40115880 | The heparin/heparan sulfate sequence that interacts with cyclophilin B contains a 3-O-sulfated N-unsubstituted glucosamine residue. |
| Q24634299 | Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication |
| Q33705063 | Vaginal Lactobacillus Inhibits HIV-1 Replication in Human Tissues Ex Vivo |
| Q35661728 | Valacyclovir Decreases Plasma HIV-1 RNA in HSV-2 Seronegative Individuals: A Randomized Placebo-Controlled Crossover Trial |
| Q35635030 | Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation |
| Q40075273 | Virtual screening of acyclovir derivatives as potential antiviral agents: design, synthesis and biological evaluation of new acyclic nucleoside ProTides |
| Q37633738 | War and peace between microbes: HIV-1 interactions with coinfecting viruses |
Search more.